≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Hypoplasia of dental enamel, prenatal

Endpoint Browser PheWeb

K11_HYPOPLASIA_ENAMEL_PRENATAL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K00.41
  • Cause of death: ICD-10 — K00.41

2 out of 7 registries used, show all original rules.

65

4. Check minimum number of events

None

65

5. Include endpoints

None

65

6. Filter based on genotype QC (FinnGen only)

65

Control definitions (FinnGen only)

Control exclude
K11_MIH

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 444 197 247
Only index persons 110 54 56
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population - 4.63 4.01
Only index persons 8.81 9.75 7.90

-FinnGen-

Key figures

All Female Male
Number of individuals 65 29 36
Unadjusted period prevalence (%) 0.01 0.01 0.02
Median age at first event (years) 4.38 5.00 3.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
57
Matched controls
572
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K00.41
ICD-10 Finland
Prenatal enamel hypoplasia
+∞
81.7
57
*
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
+∞
44.8
37
*
127
Kela drug reimbursment
Transplant complication
59.0
24.5
28
9
L04AX01
ATC
azathioprine; systemic
48.2
23.4
28
11
SAA03
NOMESCO Finland
Extended examination of mouth
109.6
22.8
56
192
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
80.4
22.3
24
5
H02AB04
ATC
methylprednisolone; systemic
44.9
22.3
27
11
Z94.0
ICD-10 Finland
Kidney transplant status
66.9
21.6
24
6
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
27.3
21.0
30
22
ZX120
NOMESCO Finland
Intravenous
19.4
20.1
34
40
R4110
NOMESCO Finland
Physiotherapy
18.5
19.3
49
141
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
24.9
19.2
28
21
A11CC03
ATC
alfacalcidol; systemic
41.4
18.8
23
9
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
+∞
18.8
17
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
20.6
18.7
51
166
H02AB09
ATC
hydrocortisone; systemic
19.1
17.8
29
29
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
59.9
17.7
20
5
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.7
17.6
38
72
WX408
NOMESCO Finland
General anesthesy, balanced
18.5
17.3
51
179
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
40.3
17.1
21
8
137
Kela drug reimbursment
Uraemia requiring dialysis
85.5
16.9
18
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
31.5
16.8
22
11
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
42.8
16.6
20
7
EBA15
NOMESCO Finland
Extraction of large number of teeth
19.7
16.6
26
23
KAC00
NOMESCO Finland
Nephrectomy
64.0
16.2
18
*
L04AA06
ATC
mycophenolic acid; systemic
32.2
16.2
21
10
K03.00
ICD-10 Finland
Approximal wear
39.6
15.5
19
7
C08CA01
ATC
amlodipine; oral
21.7
15.5
23
17
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
108.6
15.5
16
*
TPH07
NOMESCO Finland
Cathetrisation of artery
10.9
15.0
36
77
L04AD01
ATC
ciclosporin; systemic
24.7
14.9
21
13
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
19.4
14.8
23
19
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
11.7
14.8
32
56
TK800
NOMESCO Finland
Hemodialysis
72.4
14.7
16
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
10.4
14.6
43
129
K03.66
ICD-10 Finland
Tooth plaque
10.8
14.4
33
64
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
14.0
14.2
26
32
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
15.7
14.1
24
25
A12AA04
ATC
calcium carbonate; oral
54.2
14.0
16
*
B03XA01
ATC
erythropoietin; parenteral
54.2
14.0
16
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
11.2
13.6
29
48
K02.0
ICD-10 Finland
Caries limited to enamel
9.5
13.6
35
81
TPH04
NOMESCO Finland
Cathetrisation of vein
9.7
13.6
34
75
GD1AA
NOMESCO Finland
Thorax X-ray examination
9.2
13.3
42
133
Z99.2
ICD-10 Finland
Dependence on renal dialysis
90.7
13.3
14
*
TK820
NOMESCO Finland
Peritoneal dialysis
90.7
13.3
14
*
B05DA
ATC
Isotonic solutions
164.8
13.0
13
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
36.1
12.9
16
6
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
10.0
12.7
29
53
IGY02
NOMESCO Finland
Psychiatric monitoring contact
12.5
12.6
24
31
SAA04
NOMESCO Finland
Special inverstigation of mouth
17.4
12.6
20
17
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
60.5
12.5
14
*
ZX199
NOMESCO Finland
Other rote
30.9
12.4
16
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
8.1
12.1
37
106
205
Kela drug reimbursment
Chronic hypertension
19.5
12.0
18
13
Z49.1
ICD-10 Finland
Extracorporeal dialysis
+∞
11.9
11
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
7.7
11.7
36
103
K06.18
ICD-10 Finland
Another gingival hyperplasia
36.2
11.4
14
5
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
11.6
11.3
22
29
Z49.2
ICD-10 Finland
Other dialysis
74.4
11.1
12
*
WX110
NOMESCO Finland
Local anesthesy
9.2
11.0
49
228
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
8.0
10.9
29
65
ZXA00
NOMESCO Finland
Right side
8.7
10.8
26
50
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
14.9
10.8
18
17
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
+∞
10.7
10
*
1AB02
NOMESCO Finland
NA
22.0
10.6
15
9
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
14.0
10.5
18
18
5AB14
NOMESCO Finland
NA
66.8
10.0
11
*
SCE00
NOMESCO Finland
Fissure closure of tooth
7.0
9.9
29
73
RS220
NOMESCO Finland
NA
17.9
9.9
15
11
4AA09
NOMESCO Finland
NA
37.1
9.9
12
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
15.3
9.8
16
14
WW500
NOMESCO Finland
Blood transfusion
12.0
9.7
18
21
SFA40
NOMESCO Finland
Replacement of krone of tooth
20.1
9.6
14
9
WX882
NOMESCO Finland
High dependency care
6.1
9.4
34
111
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
29.7
9.4
12
5
602
Kela drug reimbursment
Children's severe malnutrition
8.9
9.3
21
35
RD210
NOMESCO Finland
NA
8.3
9.3
22
40
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
8.1
9.1
22
41
XF400
NOMESCO Finland
ECG with 12 standard connections
5.7
8.9
36
131
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
24.7
8.9
12
6
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
33.3
8.9
11
*
R50.9
ICD-10 Finland
Fever, unspecified
5.6
8.8
36
133
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
13.1
8.7
15
15
K02.1
ICD-10 Finland
Caries of dentine
5.5
8.5
38
152
RS121
NOMESCO Finland
NA
14.9
8.1
13
11
FM2CE
NOMESCO Finland
NA
5.7
8.0
27
77
L04AA01
ATC
[U] ciclosporin; systemic
29.7
7.9
10
*
I15.8
ICD-10 Finland
Other secondary hypertension
29.7
7.9
10
*
ZXA05
NOMESCO Finland
Left side
7.6
7.8
19
35
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
11.9
7.8
14
15
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
5.1
7.8
33
121
A41.9
ICD-10 Finland
Sepsis, unspecified
16.5
7.8
12
9
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
16.5
7.8
12
9
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
5.6
7.7
26
74
V03AE01
ATC
polystyrene sulfonate; oral
91.5
7.6
8
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
12.5
7.5
13
13
3A013
NOMESCO Finland
NA
34.9
7.4
9
*
XA800
NOMESCO Finland
Neuropsychological investigation
5.4
7.3
25
72
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
13.4
7.2
12
11
ZXA10
NOMESCO Finland
Bilateral
5.3
7.0
24
68
N18.8
ICD-10 Finland
Other chronic renal failure
19.8
7.0
10
6
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.6
7.0
22
57
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
45.6
6.9
8
*
XF602
NOMESCO Finland
Bloodpressure monitoring
26.2
6.9
9
*
SAB03
NOMESCO Finland
Oral health check
0.2
6.8
22
420
XX4AW
NOMESCO Finland
NA
8.1
6.7
15
24
JAF10
NOMESCO Finland
Repair of umbilical hernia
78.3
6.6
7
*
TK823
NOMESCO Finland
Peritoneal permeability analysis
78.3
6.6
7
*
783
NOMESCO Finland
NA
30.4
6.4
8
*
C07AB02
ATC
metoprolol; systemic
14.8
6.4
10
8
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.4
6.3
27
96
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
9.8
6.2
12
15
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
17.4
6.1
9
6
IEP02
NOMESCO Finland
Child-centred family therapy
6.3
6.0
16
33
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.9
6.0
17
38
UDC00
NOMESCO Finland
Ear microscopy
7.4
6.0
14
24

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
31
36
15.55
26.92
5.8
2.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
21
12
25.38
26.70
5.3
3.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
28
28
16.81
26.70
2.7
2.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
26
23
18.17
26.63
2.9
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
31
37
15.11
26.39
5.8
2.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
46
109
12.02
22.45
55.1
12.1
mmol/l
0.7
0.8
5.70
46
104
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
44
101
11.39
21.99
61.1
18.4
mg/l
1.4
1.0
4.24
44
101
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
25
7
56.41
21.82
8.0
6.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
25
7
56.41
21.82
11.7
9.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
25
7
56.41
21.82
8.0
6.3
—
—
—
0
0
(4035726)
27
34
12.87
21.77
2.3
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
23
14.93
21.57
3.0
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
51
144
12.80
20.98
10.6
3.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
44
11.09
20.24
5.4
2.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
44
11.09
20.24
5.3
2.2
u/ml
147.7
103.2
0.50
18
14
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
27
38
11.44
19.92
3.5
2.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
133
10.98
19.80
9.4
3.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
39
89
9.46
19.11
20.6
8.2
umol/l
5.4
6.6
0.37
31
68
(40768446) Kidney Pathology biopsy report
23
8
43.30
19.04
3.2
2.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
43
110
9.60
18.92
9.1
3.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
47
134
10.05
18.60
16.3
5.9
s
32.1
31.1
0.26
47
134
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
30
11.32
17.79
2.3
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
37
10.35
17.56
3.2
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
51
167
10.54
17.36
10.6
4.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
32
65
8.73
17.16
5.2
2.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
26
11.45
16.79
2.8
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
56
213
12.72
16.49
55.4
8.8
mmol/l
1.4
1.5
1.00
56
204
(3042936) Bacteria identified in Isolate by Culture
30
60
8.43
16.20
3.1
1.9
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
17
13.19
15.61
5.4
3.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
17
17
13.19
15.61
5.4
4.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
35
87
7.55
15.24
18.7
7.8
%
90.2
87.5
0.22
35
87
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
27
10.26
14.88
2.5
2.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
19
25
10.33
14.38
8.4
6.8
%
0.0
1.4
—
12
7
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14
12
14.59
14.00
1.1
1.3
pmol/l
721.2
585.2
0.56
14
12
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
33
84
6.95
13.83
4.1
2.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
77
6.78
13.24
3.5
2.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
77
6.78
13.24
4.0
2.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
19
28
9.18
13.09
9.3
6.7
%
0.1
0.8
0.76
14
11
(3000494) Fungus identified in Specimen by Culture
24
47
7.51
12.91
2.2
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
53
222
8.52
12.71
37.7
10.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
35
101
6.34
12.66
15.3
3.3
ph
7.4
7.4
—
6
11
(3025159) Blasts/100 leukocytes in Blood
18
26
9.19
12.57
8.9
7.0
%
0.0
0.0
—
12
9
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
25
55
6.76
11.93
10.4
11.9
ng/l
2990.8
1370.3
0.75
25
50
(3052851) Hemolysis interference index of Serum or Plasma
19
32
7.98
11.61
6.6
3.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
40
7.28
11.48
1.8
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
62
6.32
11.37
2.5
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
45
6.88
11.22
1.7
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
14
11.36
11.15
2.1
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
43
163
5.84
11.07
9.9
3.5
mmol/l
1.2
1.2
0.09
43
156
(3026008) Bacteria identified in Urine by Culture
35
112
5.60
10.99
6.9
2.3
—
—
—
0
0
(44790047)
19
34
7.48
10.96
3.5
2.1
—
—
—
0
0
(44806118)
19
34
7.48
10.96
3.5
2.1
—
—
—
0
0
(44790048)
19
34
7.48
10.96
3.5
2.1
—
—
—
0
0
(44790049)
19
34
7.48
10.96
3.5
2.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
52
234
7.11
10.89
50.9
9.6
kpa
5.5
5.7
1.10
52
227
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
48
205
6.13
10.58
17.6
4.2
nmol/l
88.6
72.0
6.48
48
199
(3042733) HLA Ab [Presence] in Serum
14
7
24.93
10.33
3.0
2.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
14
7
24.93
10.33
1.4
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
26
68
5.71
10.17
2.3
1.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
50
229
6.13
9.91
47.9
9.5
kpa
5.5
5.5
0.04
50
222
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
17
30
7.32
9.86
25.1
23.0
%
0.7
0.7
0.00
17
30
(3004119) Hemoglobin [Mass/volume] in Venous blood
19
38
6.65
9.80
44.1
19.7
g/l
117.6
123.2
0.44
19
38
(3001122) Ferritin [Mass/volume] in Serum or Plasma
48
214
5.75
9.79
11.3
3.7
ug/l
74.0
50.0
0.69
48
206
(40758558) Short blood count panel - Blood
56
301
7.20
9.69
34.4
9.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
52
252
6.32
9.47
48.4
9.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
15
24
7.83
9.46
10.5
4.6
%
93.5
93.3
0.01
15
24
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
42
172
5.07
9.42
10.2
3.3
mmol/l
2.4
2.5
0.26
42
163
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
42
172
5.07
9.42
10.1
3.3
mmol/l
1.4
1.3
0.09
42
161
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
17
32
6.84
9.25
25.1
21.7
%
1.1
1.2
0.03
17
32
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
12
15
9.58
9.17
14.2
7.0
mg/l
9.2
10.3
0.15
12
15
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
53
271
6.18
8.76
24.6
4.4
u/l
207.8
201.6
0.15
53
260
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
9
17.63
8.63
3.1
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
9
17.63
8.63
1.5
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
14
23
7.48
8.58
3.3
4.5
umol/l
21.6
29.1
0.88
14
23
(3007853) Bacteria identified in Skin by Aerobe culture
31
108
4.58
8.37
3.8
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
36
142
4.44
8.21
23.3
7.8
u/l
36.7
28.0
0.49
36
142
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
54
5.27
8.20
1.7
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
50
252
5.26
8.19
22.9
4.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
21
7.49
8.05
16.7
4.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
34
131
4.35
7.95
6.9
2.7
mmol/l
2.4
2.4
0.39
34
119
(40761535) Cells panel - Urine sediment
11
6
21.63
7.91
6.2
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
13
22
7.14
7.71
3.0
2.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
52
280
5.29
7.57
52.8
10.1
mmol/l
1.2
1.1
0.04
47
194
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
51
271
5.09
7.54
26.3
4.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
19
7.52
7.53
1.4
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
10
13
8.91
7.33
2.0
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
13
8.91
7.33
18.7
6.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
58
374
6.10
6.97
95.5
16.4
mmol/l
1.2
1.2
0.55
58
363
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
39
180
3.92
6.81
14.4
4.2
e6/l
1.0
0.5
0.40
33
116
(3016038) Potassium [Moles/volume] in Urine
12
22
6.46
6.56
2.4
3.0
mmol/l
26.8
31.5
0.24
12
22
(1175426) CD3 cells/100 lymphocytes in Blood
16
39
5.12
6.53
6.5
4.2
%
72.9
65.4
0.56
16
39
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
39
5.12
6.53
6.4
4.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
5
20.52
6.46
24.8
12.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
58
380
5.88
6.45
104.8
14.0
mmol/l
1.2
1.2
0.31
58
365
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
51
291
4.49
6.37
63.0
14.1
mmol/l
24.5
24.4
0.02
51
291
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
39
187
3.71
6.29
17.0
4.1
e6/l
2.7
0.5
0.69
34
123
(3027273) Bicarbonate [Moles/volume] in Venous blood
13
27
5.77
6.28
36.1
6.5
mmol/l
23.9
23.3
0.20
13
27
(42870588) Differential panel, method unspecified - Blood
57
377
5.15
6.05
40.6
10.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
20
6.42
6.03
2.2
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
12
24
5.91
6.01
34.7
25.9
%
78.1
75.8
0.30
12
24
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
32
140
3.53
5.86
5.2
4.1
mg/l
3.2
2.6
0.95
32
131
(40760892) CBC W Ordered Manual Differential panel - Blood
20
64
4.07
5.78
22.0
4.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
5
17.93
5.56
2.4
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
50
4.25
5.47
2.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
50
4.25
5.47
2.6
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
60
430
6.13
5.39
55.2
11.1
e9/l
0.0
0.0
0.50
52
302
(3011397) Hemoglobin [Presence] in Urine by Test strip
37
185
3.32
5.35
11.4
3.2
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
0
+∞
5.27
1.2
0.0
—
—
—
0
0
(3002256) Pathology report gross observation
11
23
5.55
5.23
1.5
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
10
10.21
4.96
1.2
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
20
5.73
4.95
37.3
30.6
%
11.8
11.7
—
10
20
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
20
5.73
4.95
4.4
2.5
—
—
—
0
0
(3015736) pH of Urine
35
176
3.14
4.90
13.7
3.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
29
4.85
4.86
4.3
3.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
25
5.09
4.77
37.1
26.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
30
4.68
4.67
2.3
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
30
4.68
4.67
2.1
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
32
157
3.04
4.62
2.3
1.5
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
9
13
7.83
4.32
2.3
2.8
umol/l
13.5
11.4
—
9
13
(21494815) CD4 cells/100 lymphocytes in Specimen
13
37
4.14
4.30
7.5
4.3
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
8
10
8.93
4.19
2.5
2.5
umol/l
1.0
1.1
—
8
10
(3020891) Body temperature
8
10
8.93
4.19
5.8
11.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
7
11.01
4.11
4.9
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
36
198
2.83
4.10
10.3
3.7
mmol/mol
32.9
36.7
3.06
36
185
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
24
4.74
4.05
43.3
6.3
%
52.6
65.6
—
10
24
(3013512) EKG study
11
29
4.36
3.99
3.5
3.8
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
11
8.10
3.99
1.0
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
40
237
2.79
3.88
28.5
5.3
estimate
0.0
0.0
0.00
13
24
(3035350) Ketones [Presence] in Urine by Test strip
40
237
2.79
3.88
18.9
3.2
estimate
0.0
0.0
0.00
11
22
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
22
95
2.99
3.87
27.0
5.3
ml/min/173m2
90.8
100.6
—
9
47
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
8
9.62
3.87
1.4
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
51
344
3.24
3.87
28.3
4.3
—
—
—
0
0
(3019225) pH of Specimen
6
5
13.01
3.84
24.2
2.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
40
238
2.77
3.83
19.0
3.2
estimate
0.0
0.0
0.00
13
24
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
30
4.21
3.82
1.5
2.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
9
8.54
3.65
1.9
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
65
3.19
3.65
2.6
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
6
10.84
3.57
9.0
2.3
e9/l
3.0
2.3
—
6
6
(40768441) Liver Pathology biopsy report
6
6
10.84
3.57
2.3
2.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
7
9.28
3.33
1.5
3.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
7
9.28
3.33
9.8
2.4
%
43.8
40.9
—
6
7
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
12
39
3.55
3.28
7.0
4.2
%
29.8
23.6
1.02
12
39
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
29
3.89
3.19
11.3
26.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
13
46
3.28
3.13
2.8
2.5
u/l
3.2
2.9
—
6
21
(3013290) Carbon dioxide [Partial pressure] in Blood
6
8
8.11
3.12
26.5
6.3
kpa
4.7
4.5
—
6
8
(3034770) Mitochondria Ab [Titer] in Serum
6
8
8.11
3.12
2.8
1.9
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
6
8
8.11
3.12
26.5
6.4
kpa
11.0
8.7
—
6
8
(3041096) Erythrocytes [Presence] in Urine by Automated
17
71
2.89
3.12
18.5
2.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
7
12
6.38
3.11
10.1
2.2
mmol/l
1.7
1.5
—
7
12
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
5
10.67
3.03
2.4
4.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
5
10.67
3.03
1.2
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
5
10.67
3.03
1.2
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
48
336
2.64
2.99
22.5
4.0
mm/h
9.4
9.1
0.10
48
320
(3022145) Colonoscopy Study observation
7
13
5.89
2.95
2.3
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
9
7.20
2.93
1.7
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
18
4.91
2.90
1.3
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
6
8.89
2.79
1.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
6
8.89
2.79
1.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
6
8.89
2.79
1.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
6
8.89
2.79
1.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
6
8.89
2.79
1.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
6
8.89
2.79
1.2
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
6
8.89
2.79
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
6
8.89
2.79
2.2
1.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
6
8.89
2.79
1.0
1.0
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
10
32
3.51
2.78
11.4
26.5
%
1.0
0.9
—
10
32
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
10
32
3.51
2.78
11.4
26.5
%
0.8
0.7
—
10
32
(3014007) Fractional oxyhemoglobin in Arterial blood
10
32
3.51
2.78
11.4
26.6
%
94.9
94.0
—
10
32
(3022493) Free Hemoglobin [Mass/volume] in Plasma
6
10
6.48
2.76
10.7
2.2
mg/l
66.2
76.4
—
6
10
(3029937) Albumin [Presence] in Urine by Test strip
20
97
2.53
2.74
18.0
2.5
estimate
0.0
0.0
0.00
11
25
(3024932) HLA-DR beta [Type]
6
11
5.88
2.60
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
6
11
5.88
2.60
1.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
12
5.38
2.46
5.8
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
22
3.99
2.45
18.4
3.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
10
35
3.19
2.42
11.4
23.7
mmol/l
23.2
24.1
—
10
35
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
28
3.56
2.41
1.6
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
8
6.65
2.41
3.2
2.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
5
8
6.65
2.41
1.2
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
61
0.00
2.39
0.0
1.2
—
10.9
—
0
46
(4306422)
5
9
5.91
2.25
1.0
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
9
5.91
2.25
1.2
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
14
4.60
2.20
1.3
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
56
0.00
2.19
0.0
1.2
—
0.3
—
0
36
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
58
0.00
2.17
0.0
1.2
—
8.0
—
0
41
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
9
31
3.20
2.17
6.1
2.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
38
2.93
2.12
3.0
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
20
3.79
2.12
2.0
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
10
5.31
2.11
1.2
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
10
5.31
2.11
1.2
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
5
10
5.31
2.11
1.2
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
10
5.31
2.11
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
10
5.31
2.11
1.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
15
4.29
2.09
1.3
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
11
45
2.74
2.05
3.2
2.5
iu/l
5.1
8.7
—
6
24
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
11
4.82
1.98
1.0
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
22
127
2.11
1.96
16.6
2.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
13
4.07
1.75
1.2
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
6
19
3.37
1.70
3.0
3.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
14
3.77
1.64
1.4
3.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
14
3.77
1.64
1.4
3.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
10
45
2.44
1.55
6.0
5.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
45
2.44
1.55
6.2
5.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
15
3.52
1.55
5.0
4.9
ug/l
28.9
24.2
—
5
15
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
21
3.04
1.54
2.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
16
3.29
1.46
4.0
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
30
214
1.75
1.35
2.4
2.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
34
2.54
1.35
4.5
6.4
ug/l
3.9
2.6
—
8
34
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
24
2.65
1.33
2.2
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
15
87
1.94
1.29
4.1
2.5
u/l
114.1
581.9
0.89
15
87
(42529406) Shigella sp [Presence] in Stool by Culture
6
25
2.54
1.27
2.2
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
20
2.62
1.17
2.0
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
40
2.14
1.17
1.5
1.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
21
2.49
1.11
1.6
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
21
2.49
1.11
4.6
2.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
21
2.49
1.11
1.6
1.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
9
48
2.01
1.06
6.8
4.9
mg/l
1202.2
373.3
—
9
48
(36660697) Celiac disease serology panel - Serum
9
151
0.53
1.06
1.3
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
65
622
+∞
1.00
117.6
18.3
fl
84.5
82.7
2.09
65
617
(4010399)
0
30
0.00
1.00
0.0
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
6
30
2.10
0.89
4.2
3.4
mg/mmol
2045.4
12.7
—
6
18
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
31
2.03
0.87
2.2
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
32
1.96
0.84
5.8
4.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
65
624
+∞
0.80
117.7
18.3
e9/l
7.6
7.7
0.10
65
585
(3026361) Erythrocytes [#/volume] in Blood
65
623
+∞
0.79
117.6
18.3
e12/l
4.2
4.5
5.64
65
583
(3035941) MCH [Entitic mass]
65
623
+∞
0.79
117.6
18.3
pg
28.4
27.9
1.60
65
618
(3007461) Platelets [#/volume] in Blood
65
623
+∞
0.79
117.6
18.5
e9/l
286.9
289.7
0.09
65
586
(3000963) Hemoglobin [Mass/volume] in Blood
65
623
+∞
0.79
119.4
19.3
g/l
117.6
125.9
4.61
65
618
(3022621) pH of Urine by Test strip
5
24
2.17
0.76
3.6
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
24
2.17
0.76
2.4
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
37
307
1.48
0.76
3.2
1.8
g/l
1.6
1.1
1.30
29
124
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
7
41
1.79
0.72
1.0
1.0
g/l
172.6
162.7
—
7
41
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
26
2.00
0.72
1.2
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
26
2.00
0.72
1.6
1.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
19
0.00
0.61
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
34
1.84
0.60
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
6
39
1.59
0.54
2.8
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
31
1.66
0.44
1.2
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
58
547
1.56
0.44
4.8
4.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
32
1.61
0.43
1.2
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
62
1.33
0.29
1.1
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
63
1.31
0.29
1.3
1.1
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
11
87
1.32
0.26
1.0
1.0
mmol/l
20.1
19.3
0.36
11
87
(3044889) 12 lead EKG panel
18
153
1.24
0.26
4.9
1.8
—
—
—
0
0
(3006598) pH of Arterial cord blood
11
88
1.30
0.24
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
79
1.31
0.24
1.4
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
278
0.84
0.23
2.4
2.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
3.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
38
364
1.11
0.10
3.9
3.1
pmol/l
14.3
14.5
0.22
38
348
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
94
0.83
0.07
1.1
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
157.8
—
0
6
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
33.0
—
0
5
(3011985) Renin [Units/volume] in Plasma
0
7
0.00
0.00
0.0
1.7
—
1221.8
—
0
7
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
6.0
—
0
8
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
0.6
—
0
7
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
111.6
—
0
7
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_HYPOPLASIA_ENAMEL_PRENATAL and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_HYPOPLASIA_ENAMEL_PRENATAL.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: K11_HYPOPLASIA_ENAMEL_PRENATAL – Hypoplasia of dental enamel, prenatal

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data